<DOC>
	<DOCNO>NCT00124332</DOCNO>
	<brief_summary>The purpose study determine rimonabant 20 mg daily ( od ) administer 18-20 month reduce progression coronary atherosclerosis assess intravascular ultrasound ( IVUS ) administer top standard behavioral pharmacological therapy give need , patient abdominal obesity associate current smoking and/or metabolic syndrome .</brief_summary>
	<brief_title>STRADIVARIUS ( Strategy To Reduce Atherosclerosis Development InVolving Administration Rimonabant - Intravascular Ultrasound Study )</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Written sign inform consent Indication coronary angiography Abdominal obesity define waist circumference &gt; 88 cm woman &gt; 102 cm men At least one two follow condition : *a ) Metabolic syndrome define presence least two follow additional risk factor : 1 . Triglyceride level &gt; = 150 mg/dL ( 1.69 mmol/L ) ; 2 . HDL cholesterol &lt; 40 mg/dL ( 1.03 mmol/L ) [ men ] 50 mg/dL ( 1.28 mmol/L ) [ woman ] ; 3 . Fasting glucose &gt; = 110 mg/dL ( 6.1 mmol/L ) ; 4 . High blood pressure ( &gt; = 140 mmHg systolic and/or &gt; = 90 mmHg diastolic ) Screening visit , current treatment antihypertensive medication ; *b ) Currently smoke ( &gt; 10 cigarette /day ) willing stop Angiographic evidence coronary heart disease define least 1 lesion native coronary artery &gt; = 20 % reduction lumen diameter angiographic visual estimation Presence least one coronary artery comply definition `` target vessel '' IVUS assessment Acceptation Baseline IVUS tape IVUS Core Laboratory Age &lt; 18 year Pregnant breastfeeding woman History lowcalorie diet surgical procedure weight loss ( eg , stomach stapling , bypass ) within 6 month prior screen visit Obesity know endocrine origin Uncontrolled diabetes HBA1c &gt; 10 % Presence severe medical psychological condition , opinion Investigator would compromise subject 's safety successful participation study Severe congestive heart failure ( New York Heart Association [ NYHA ] Class III IV ) Clinically significant heart disease opinion Investigator likely require coronary artery bypass graft ( CABG ) , percutaneous coronary intervention ( PCI ) , cardiac transplantation , surgical repair and/or replacement course study Angioplasty nonqualifying artery consider high risk acute complication restenosis , baseline catheterization &gt; 50 % reduction lumen diameter leave main coronary artery visual angiographic estimation Recent STelevation myocardial infarction ( MI ) &lt; = 72 hour prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>